Methods for the reduction of transfusion‐transmitted cytomegalovirus infection: filtration versus the use of seronegative donor units

This publication has 72 references indexed in Scilit:

• Prevalence of markers for human immunodeficiency virus types 1 and 2, human T‐lymphotropic virus type I, cytomegalovirus, and hepatitis B and C virus in multiply transfused thalassemia patients. The French Study Group On Thalassaemia
  Transfusion, 1992
• Prevention of transfusion‐associated cytomegalovirus infection in neonatal patients by the removal of white cells from blood
  Transfusion, 1992
• Experimental 6 log₁₀ white cell‐reduction filters for red cells
  Transfusion, 1992
• A Randomized, Controlled Trial of Prophylactic Ganciclovir for Cytomegalovirus Pulmonary Infection in Recipients of Allogeneic Bone Marrow Transplants
  New England Journal of Medicine, 1991
• Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products
  Transfusion, 1989
• USE OF LEUCOCYTE‐POOR BLOOD COMPONENTS TO PREVENT PRIMARY CYTOMEGALOVIRUS (CMV) INFECTION IN PATIENTS WITH ACUTE LEUKAEMIA
  British Journal of Haematology, 1988
• Prevention of Transfusion-Associated Cytomegalovirus (CMV) Infection in Neonates by Screening Blood Donors for IgM to CMV
  The Journal of Infectious Diseases, 1988
• Posttransfusion cytomegalovirus infection in neonates: Role of saline-washed red blood cells
  The Journal of Pediatrics, 1986
• Comparison of three methods for detecting antibody to cytomegalovirus
  Transfusion, 1986
• Prevention of transfusion-acquired cytomegalovirus infections in newborn infants
  The Journal of Pediatrics, 1981